breast cancer neoadjuvant

Release time ：Dec-20,2024

Neoadjuvant therapy in breast cancer is a pre-surgical treatment approach designed to downsize tumors, thereby enhancing surgical outcomes and survival rates. This modality may encompass a range of treatments including chemotherapy, radiotherapy, or hormone therapy.

Chemotherapy, the most frequently utilized method in neoadjuvant therapy, can be delivered via intravenous infusion or orally. The mechanism of chemotherapy drugs is to target and destroy rapidly dividing cancer cells, which helps to reduce the tumor mass. Radiotherapy employs high-energy radiation to eliminate cancer cells and is typically administered subsequent to chemotherapy. Hormone therapy is primarily indicated for patients with hormone receptor-positive breast cancer, functioning by impeding the effects of estrogen to curb tumor growth.

It is important to recognize that while neoadjuvant therapy can boost the likelihood of successful surgery, it is not without side effects, such as nausea, vomiting, and alopecia. Patients undergoing neoadjuvant therapy should therefore be under the supervision of a physician, strictly follow medical instructions, and avoid self-medicating without guidance. Additionally, patients are advised to focus on dietary habits, rest, and psychological well-being to bolster their resilience and better manage the discomforts associated with treatment.

In conclusion, while neoadjuvant therapy for breast cancer is a potent treatment option, patients must vigilantly monitor their health status, promptly communicate any adverse effects to their healthcare provider to facilitate adjustments to the treatment regimen. Maintaining a positive mindset and actively engaging in the treatment process are also crucial for a swift recovery.